Baird Financial Group’s Abiomed Inc ABMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-109,682	Closed	-$26.9M	–	1793
2022 Q3	$26.9M	Sell	109,682 -1,439	-1%	-$389K	0.08%	240
2022 Q2	$27.5M	Buy	111,121 +39,458	+55%	+$10.6M	0.08%	254
2022 Q1	$23.7M	Sell	71,663 -36,421	-34%	-$11.2M	0.06%	285
2021 Q4	$38.8M	Sell	108,084 -1,464	-1%	-$495K	0.09%	214
2021 Q3	$35.7M	Sell	109,548 -8,115	-7%	-$2.75M	0.09%	217
2021 Q2	$36.7M	Buy	117,663 +37,048	+46%	+$11.4M	0.1%	215
2021 Q1	$25.7M	Sell	80,615 -36,557	-31%	-$11.7M	0.07%	247
2020 Q4	$38M	Buy	117,172 +4,210	+4%	+$1.16M	0.11%	209
2020 Q3	$31.3M	Sell	112,962 -12,716	-10%	-$3.66M	0.11%	217
2020 Q2	$30.4M	Sell	125,678 -8,327	-6%	-$1.67M	0.11%	204
2020 Q1	$19.4M	Buy	134,005 +97,006	+262%	+$16.1M	0.09%	234
2019 Q4	$6.32M	Sell	36,999 -174,393	-82%	-$32.3M	0.02%	482
2019 Q3	$37.6M	Buy	211,392 +5,418	+3%	+$1.17M	0.15%	170
2019 Q2	$53.7M	Buy	205,974 +115,170	+127%	+$30.6M	0.21%	125
2019 Q1	$26M	Buy	90,804 +5,104	+6%	+$1.7M	0.15%	181
2018 Q4	$27.9M	Buy	85,700 +22,224	+35%	+$7.72M	0.19%	146
2018 Q3	$28.2M	Buy	63,476 +51,999	+453%	+$20.5M	0.18%	153
2018 Q2	$4.7M	Buy	11,477 +4,574	+66%	+$1.66M	0.03%	450
2018 Q1	$2.01M	Buy	6,903 +4,492	+186%	+$1.14M	0.01%	643
2017 Q4	$452K	Buy	2,411 +193	+9%	+$36K	﹤0.01%	1041
2017 Q3	$374K	Buy	+2,218	New	+$335K	﹤0.01%	1056
2016 Q4	–	Sell	-19,941	Closed	-$2.56M	–	1275
2016 Q3	$2.56M	Buy	+19,941	New	+$2.39M	0.02%	499

Other funds holding ABMD